EU Law of Competition and Trade in the Pharmaceutical Sector
EU Law of Competition and Trade in the Pharmaceutical Sector
Figueroa, Pablo; Guerrero, Alejandro
Edward Elgar Publishing Ltd
06/2019
864
Dura
Inglês
9781785362606
15 a 20 dias
1. Competition Law and Pharma: An Economic Perspective
Benoit Durand
2. Reverse Payments: an EU and U.S. Perspective
Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon
3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical Sector
Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck
4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical Sector
Pierre Moullet
5. Article 102 TFEU: Patent filings as an abuse of dominant position after "AstraZeneca": the patent / antitrust interface under a new perspective
Francisco Hernandez
6. Mergers in the Pharmaceutical Sector
Pablo Figueroa and Alejandro Guerrero
7. Mergers in the Medical Devices Sector
Jan Heithecker
8. Antitrust Practices in Pharmaceutical Public Procurement
Antonio Minho Lopez
9. EU Trade Law and Pharmaceuticals
Pascale Hecker
10. The Pharmaceutical Sector and Parallel Trade
Edurne Navarro Varona and Cristina Caballero
11. Free Movement and Competition in the European Market for Pharmaceuticals
Pedro Caro de Sousa
12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical Sector
Rais Amils
13. The EU Regulatory Framework for Medical Products for Human Use
Marc Martens and Nicolas Carbonnelle
14. Antitrust and the Pharmaceutical Industry in the United States
George A. Hay
15. UK Competition and Trade in the Pharma Sector
Paula Riedel
16. Competition law and Pharma: China
Andrew Foster
17. Competition Law and Pharma: Spain
Helmut Brokelmann and Mariarosaria Ganino
18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS
Maria Ioannidou and Ioannis Kokkoris
19. Product Hopping: The U.S. Approach
Michael A. Carrier
20. Marketing data in the Pharmaceutical Sector: a competition law consideration
Pedro Callol
Index
1. Competition Law and Pharma: An Economic Perspective
Benoit Durand
2. Reverse Payments: an EU and U.S. Perspective
Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon
3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical Sector
Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck
4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical Sector
Pierre Moullet
5. Article 102 TFEU: Patent filings as an abuse of dominant position after "AstraZeneca": the patent / antitrust interface under a new perspective
Francisco Hernandez
6. Mergers in the Pharmaceutical Sector
Pablo Figueroa and Alejandro Guerrero
7. Mergers in the Medical Devices Sector
Jan Heithecker
8. Antitrust Practices in Pharmaceutical Public Procurement
Antonio Minho Lopez
9. EU Trade Law and Pharmaceuticals
Pascale Hecker
10. The Pharmaceutical Sector and Parallel Trade
Edurne Navarro Varona and Cristina Caballero
11. Free Movement and Competition in the European Market for Pharmaceuticals
Pedro Caro de Sousa
12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical Sector
Rais Amils
13. The EU Regulatory Framework for Medical Products for Human Use
Marc Martens and Nicolas Carbonnelle
14. Antitrust and the Pharmaceutical Industry in the United States
George A. Hay
15. UK Competition and Trade in the Pharma Sector
Paula Riedel
16. Competition law and Pharma: China
Andrew Foster
17. Competition Law and Pharma: Spain
Helmut Brokelmann and Mariarosaria Ganino
18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS
Maria Ioannidou and Ioannis Kokkoris
19. Product Hopping: The U.S. Approach
Michael A. Carrier
20. Marketing data in the Pharmaceutical Sector: a competition law consideration
Pedro Callol
Index